September 25, 2017 – 9:10: Peptidic and Non-Peptidic Macrocycles for Challenging Targets in Drug Discovery
Steffen Weinbrenner, Ph.D., Head Drug Discovery of Polyphor Ltd., will give insight into how macrocycles as new therapeutic modalities are complementing the chemical space and help to identify chemical matter for difficult targets and target classes. A particular focus will be on how macrocycles offer chemical matter beyond the rule of 5, still being cell penetrating and orally bioavailable. A case study on macrocycle MedChem optimization will be presented.
http://www.discoveryontarget.com